Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,823Revenue $M1,302Net Margin (%)5.3Z-Score2.9
Enterprise Value $M6,326EPS $0.3Operating Margin %4.9F-Score4
P/E(ttm))84.3Cash Flow Per Share $1.7Pre-tax Margin (%)2.9Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %6.8Quick Ratio3.5Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %-5.6Current Ratio3.9Lower Leverage y-yN
Price/Cash Flow10.9y-y EBITDA Growth Rate %-23.5ROA % (ttm)1.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)2.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M233ROI % (ttm)0.4Gross Margin Increase y-yN

Gurus Latest Trades with QGEN

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
QGENRon Baron 2014-03-31 Sold Out $20.46 - $24.82
($22.48)
$ 24.9811%Sold Out0
QGENRon Baron 2013-12-31 Reduce$20.63 - $24.65
($22.54)
$ 24.9811%Reduce -49%10,200
QGENPRIMECAP Management 2013-09-30 Add0.19%$19.72 - $21.88
($20.86)
$ 24.9820%Add 60.33%17,881,461
QGENPRIMECAP Management 2013-06-30 Add0.06%$18.45 - $21.08
($19.52)
$ 24.9828%Add 22.63%11,152,875
QGENRon Baron 2013-06-30 Reduce$18.45 - $21.08
($19.52)
$ 24.9828%Reduce -45.95%20,000
QGENPRIMECAP Management 2012-09-30 Add0.06%$16.09 - $18.97
($17.62)
$ 24.9842%Add 31.89%8,579,261
QGENPRIMECAP Management 2012-06-30 Buy 0.18%$15 - $17.22
($16.24)
$ 24.9854%New holding, 6504966 sh.6,504,966
QGENRon Baron 2012-03-31 Add$14.49 - $16.76
($14.43)
$ 24.9873%Add 26.98%40,000
QGENRon Baron 2010-12-31 Add$17.02 - $19.92
($18.77)
$ 24.9833%Add 44.23%37,500
QGENRon Baron 2010-09-30 Buy $17.66 - $20.62
($18.79)
$ 24.9833%New holding, 26000 sh.26,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

QGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
QGEN PRIMECAP Management 2014-03-3122,234,5049.540.53+14.69%
QGEN Ron Baron 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


QGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about QGEN :

    Quarterly/Annual Reports about QGEN:

      News about QGEN:

      Articles On GuruFocus.com
      comment on QGEN May 14 2013 
      comment on QGEN May 10 2013 
      Biotech Gets Personal: Long on Qiagen (QGEN) & SPDR S&P Biotech (XBI) Feb 29 2012 
      Guru Stocks at 52-Week Lows: LMT, VIP, VMC, IRM, QGEN Oct 10 2010 
      Weekly Guru Bargains Highlights: QGEN, BXS, ATHR, LYV, TFSL Oct 09 2010 


      More From Other Websites
      QIAGEN advances leadership in pre-analytical solutions for next-generation sequencing (NGS) with... Jul 16 2014
      QIAGEN Advances Leadership in Pre-Analytical Solutions for Next-generation Sequencing (NGS) With... Jul 15 2014
      Qiagen Is Next Deal Candidate With Tax Allure: Real M&A Jul 07 2014
      Qiagen sees rare bullish activity Jun 23 2014
      QIAGEN Receives FDA Approval of artus® CMV RGQ MDx Kit to Monitor Cytomegalovirus (CMV) Viral Load... Jun 18 2014
      QIAGEN and Lilly Collaborate to Co-Develop Companion Diagnostics for Simultaneous Analysis of DNA... May 30 2014
      Qiagen's therascreen KRAS Gets FDA Nod May 28 2014
      Qiagen wins U.S. approval for test to accompany Amgen cancer drug May 23 2014
      Amgen gets expanded approval for colon cancer drug May 23 2014
      QIAGEN receives FDA approval of therascreen KRAS RGQ PCR Kit May 23 2014
      QIAGEN Receives FDA Approval of therascreen® KRAS RGQ PCR Kit Paired with Second Colorectal Cancer... May 23 2014
      Amgen announces FDA approval of Vectibix in combination with FOLFOX May 23 2014
      Lightning Round: Valero, Kinross Gold & More May 22 2014
      QIAGEN Integrates Content From BIOBASE, Including Widely Adopted HGMD, With its Leading Offering for... May 20 2014
      QIAGEN upgraded to Neutral from Underweight at HSBC May 13 2014
      QIAGEN has a conference call hosted by JPMorgan May 12 2014
      Qiagen NV's (QGEN) CEO Peer Schatz on Q1 2014 Results - Earnings Call Transcript May 07 2014
      QIAGEN Reports First Quarter 2014 Results and Authorizes New $100 Million Share Repurchase Program May 06 2014
      QIAGEN Receives U.S. Clearance for QIAsymphony RGQ MDx System and Diagnostic Workflow for C.... May 05 2014
      Novel Oncology and Hepatitis C Treatments Are Boosting Pharmaceutical Stocks: Citigroup Investment... Apr 28 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide